Evidence mapPaperPMID 41901285Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Danhong Injection Alleviates Blood-Brain Barrier Disruption Caused by Cerebral Ischemia-Reperfusion Injury in

Zhanhua Shi, Jingwei Wang, Kang Liu, Feiyang Ma, Haixia Du

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhanhua ShiThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.ORCID 0009-0008-3463-3590
Jingwei WangAcademy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Kang LiuCollege of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Feiyang MaCollege of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Haixia DuCollege of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.

Funding

administration of Traditional Chinese Medicine of Zhejiang Province of China 2023ZR010National Natural Science Foundation of China 82305081Zhejiang Provincial Natural Science Foundation of China LQ24H280010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blood–brain barriercerebral ischemia reperfusion injuryDanhong injectionhyperlipidemiaWnt/β-catenin signaling pathway

Identifiers

PMID41901285
PMCPMC13028738

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.